Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial Meeting Abstract
| Authors: | Gelderblom, H.; Bhadri, V. A.; Stacchiotti, S.; Bauer, S.; Wagner, A. J.; van de Sande, M.; Bernthal, N. M.; Lopez Pousa, A.; Abdul Razak, A. R.; Italiano, A.; Ahmed, M.; Le Cesne, A.; Tait, C.; Saunders, A.; Harrow, B.; Sharma, M. G.; Ruiz-Soto, R.; Sherman, M. L.; Blay, J. Y.; Tap, W. D. |
| Abstract Title: | Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | 1265 |
| Language: | English |
| ACCESSION: | WOS:001326612903088 |
| DOI: | 10.1016/j.annonc.2024.08.2321 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA78 -- Source: Wos |
